Insight Folios’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$346K Sell
1,568
-20
-1% -$4.14K 0.12% 93
2024
Q2
$312K Sell
1,588
-24
-1% -$4.96K 0.13% 85
2024
Q1
$347K Buy
1,612
+62
+4% +$13K 0.14% 81
2023
Q4
$326K Buy
1,550
+4
+0.3% +$853 0.14% 82
2023
Q3
$310K Sell
1,546
-4
-0.3% -$795 0.15% 79
2023
Q2
$287K Buy
1,550
+120
+8% +$22.2K 0.12% 93
2023
Q1
$274K Sell
1,430
-1
-0.1% -$181 0.12% 92
2022
Q4
$241K Sell
1,431
-34
-2% -$5.91K 0.11% 96
2022
Q3
$259K Sell
1,465
-683
-32% -$135K 0.13% 88
2022
Q2
$440K Buy
2,148
+55
+3% +$11.7K 0.21% 51
2022
Q1
$498K Sell
2,093
-99
-5% -$23.3K 0.22% 56
2021
Q4
$501K Buy
2,192
+141
+7% +$31K 0.23% 60
2021
Q3
$397K Buy
+2,051
New +$416K 0.22% 59

Other funds holding CME

Insight Folios's CME Position: Q3 2024 in Review

Insight Folios reduced its CME Group (CME) stake by 1.3% in Q3 2024, selling an estimated $4.14K and leaving 1,568 shares worth $346K. The position accounts for 0.12% of the portfolio, ranked #93.

Insight Folios first reported a position in CME in Q3 2021 and has held it in 13 quarters since. The position peaked at $501K in Q4 2021. 1,390 funds tracked by Wall St. Rank hold CME as of Q3 2024.

  • Insight Folios held 1,568 shares of CME Group worth $346K as of Q3 2024.
  • Insight Folios sold 20 CME Group shares in Q3 2024, an estimated $4.14K.
  • CME Group made up 0.12% of Insight Folios's portfolio in Q3 2024, its #93 holding.
  • Insight Folios first reported a position in CME Group in Q3 2021 and has held it in 13 quarters since.
  • Insight Folios's CME Group position peaked at $501K in Q4 2021.
  • 1,390 funds tracked by Wall St. Rank held CME Group as of Q3 2024.

Based on Insight Folios's 13F filing for Q3 2024, filed 24 Oct 2024.